BCAX
Bicara Therapeutics Inc.
$21.60
+$0.31(+1.46%)
70
Overall
60
Value
81
Tech
--
Quality
Market Cap
$1.39B
Volume
234.27K
52W Range
$7.80 - $21.50
Target Price
$31.50
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|
| OPERATING EXPENSES | |||||
| Operating Expenses | $37.7M | $39.9M | $82.4M | ||
| Research & Development | $31.3M | $30.6M | $63.6M | ||
| Research Expense | $31.3M | $30.6M | $63.6M | ||
| Selling, General & Administrative | $6.3M | $9.3M | $18.8M | ||
| General & Administrative Expenses | $6.3M | $9.3M | $18.8M | ||
| OPERATING INCOME | |||||
| Operating income | $-37.7M | $-39.9M | $-82.4M | ||
| EBITDA | $-37.7M | $-52.0M | $-67.9M | ||
| NON-OPERATING ITEMS | |||||
| Interest Expense (Non-Operating) | $112.0K | -- | -- | ||
| Intinc | $4.0K | $1.3M | $14.6M | ||
| Net Non-Operating Interest Income/Expense | $-108.0K | $1.3M | $14.6M | ||
| Other Income/Expense | $80.0K | $13.4M | -- | ||
| Other Special Charges | $-80.0K | -- | -- | ||
| PRE-TAX INCOME | |||||
| EBIT | $-37.7M | $-52.0M | $-68.0M | ||
| Pre-Tax Income | $-37.8M | $-52.0M | $-67.8M | ||
| INCOME TAX | |||||
| Tax Provision | $1.0K | $5.0K | -- | ||
| NET INCOME | |||||
| Net Income | $-37.8M | $-52.0M | $-68.0M | ||
| Net Income (Continuing Operations) | $-37.8M | $-52.0M | $-68.0M | ||
| Net Income (Discontinued Operations) | $-37.8M | $-52.0M | $-68.0M | ||
| Net Income (Common Stockholders) | $-37.8M | $-52.0M | $-68.0M | ||
| Normalized Income | $-27.8M | $-38.2M | $-67.1M | ||
| TOTALS | |||||
| Total Expenses | $37.7M | $39.9M | $82.4M | ||
| SHARE & EPS DATA | |||||
| Average Shares Outstanding | $429.1K | $580.1K | $16.8B | ||
| Average Shares Outstanding (Diluted) | $429.1K | $580.1K | $16.8B | ||
| Shares Outstanding | $62.6M | $62.6M | $54.5M | ||
| Basic EPS | $-88.2 | $-89.61 | $-4.05 | ||
| Basic EPS (Continuing Operations) | $-88.2 | $-89.61 | $-4.05 | ||
| Diluted EPS | $-88.2 | $-89.61 | $-4.05 | ||
| Diluted EPS (Continuing Operations) | $-88.2 | $-89.61 | $-4.05 | ||
| OTHER METRICS | |||||
| Other Gand A | $6.3M | $9.3M | $18.8M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $21.60 | +1.5% | 234.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW